365 related articles for article (PubMed ID: 33653881)
1. Assessing the costs and outcomes of control programmes for sexually transmitted infections: a systematic review of economic evaluations.
Bloch SCM; Jackson LJ; Frew E; Ross JDC
Sex Transm Infect; 2021 Aug; 97(5):334-344. PubMed ID: 33653881
[TBL] [Abstract][Full Text] [Related]
2. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
Sangani P; Rutherford G; Wilkinson D
Cochrane Database Syst Rev; 2004; (2):CD001220. PubMed ID: 15106156
[TBL] [Abstract][Full Text] [Related]
3. Are intersectoral costs considered in economic evaluations of interventions relating to sexually transmitted infections (STIs)? A systematic review.
Schnitzler L; Evers SMAA; Jackson LJ; Paulus ATG; Roberts TE
BMC Public Health; 2022 Nov; 22(1):2180. PubMed ID: 36434561
[TBL] [Abstract][Full Text] [Related]
4. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
Wilkinson D; Rutherford G
Cochrane Database Syst Rev; 2001; (2):CD001220. PubMed ID: 11405980
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness and cost-effectiveness of behavioural interventions for the prevention of sexually transmitted infections in young people aged 13-19: a systematic review and economic evaluation.
Shepherd J; Kavanagh J; Picot J; Cooper K; Harden A; Barnett-Page E; Jones J; Clegg A; Hartwell D; Frampton GK; Price A
Health Technol Assess; 2010 Feb; 14(7):1-206, iii-iv. PubMed ID: 20178696
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic reviews and mathematical modelling.
Althaus CL; Turner KM; Mercer CH; Auguste P; Roberts TE; Bell G; Herzog SA; Cassell JA; Edmunds WJ; White PJ; Ward H; Low N
Health Technol Assess; 2014 Jan; 18(2):1-100, vii-viii. PubMed ID: 24411488
[TBL] [Abstract][Full Text] [Related]
7. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.
Ng BE; Butler LM; Horvath T; Rutherford GW
Cochrane Database Syst Rev; 2011 Mar; (3):CD001220. PubMed ID: 21412869
[TBL] [Abstract][Full Text] [Related]
8. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
9. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review.
Ong JJ; Fu H; Baggaley RC; Wi TE; Tucker JD; Smith MK; Rafael S; Falconer J; Terris-Prestholt F; Mameletzis I; Mayaud P
J Int AIDS Soc; 2021 Feb; 24(2):e25673. PubMed ID: 33605081
[TBL] [Abstract][Full Text] [Related]
10. Intersectoral costs of sexually transmitted infections (STIs) and HIV: a systematic review of cost-of-illness (COI) studies.
Schnitzler L; Jackson LJ; Paulus ATG; Roberts TE; Evers SMAA
BMC Health Serv Res; 2021 Oct; 21(1):1179. PubMed ID: 34715866
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of antimicrobial resistance in curable sexually transmitted infections; a systematic review and a case study.
Ayinde O; Ross JDC; Jackson L
PLoS One; 2023; 18(10):e0292273. PubMed ID: 37856496
[TBL] [Abstract][Full Text] [Related]
12. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
[TBL] [Abstract][Full Text] [Related]
13. Strategies for partner notification for sexually transmitted infections, including HIV.
Ferreira A; Young T; Mathews C; Zunza M; Low N
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD002843. PubMed ID: 24092529
[TBL] [Abstract][Full Text] [Related]
14. The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.
Tappenden P; Campbell F; Rawdin A; Wong R; Kalita N
Health Technol Assess; 2012; 16(20):1-72. PubMed ID: 22490205
[TBL] [Abstract][Full Text] [Related]
15. Web-Based Service Provision of HIV, Viral Hepatitis, and Sexually Transmitted Infection Prevention, Testing, Linkage, and Treatment for Key Populations: Systematic Review and Meta-analysis.
Yeh PT; Kennedy CE; Minamitani A; Baggaley R; Shah P; Verster A; Luhmann N; de Mello MB; Macdonald V
J Med Internet Res; 2022 Dec; 24(12):e40150. PubMed ID: 36548036
[TBL] [Abstract][Full Text] [Related]
16. One to one interventions to reduce sexually transmitted infections and under the age of 18 conceptions: a systematic review of the economic evaluations.
Barham L; Lewis D; Latimer N
Sex Transm Infect; 2007 Oct; 83(6):441-6. PubMed ID: 17626115
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
[TBL] [Abstract][Full Text] [Related]
18. The Effectiveness of HIV Prevention Interventions in Socioeconomically Disadvantaged Ethnic Minority Women: A Systematic Review and Meta-Analysis.
Ruiz-Perez I; Murphy M; Pastor-Moreno G; Rojas-García A; Rodríguez-Barranco M
Am J Public Health; 2017 Dec; 107(12):e13-e21. PubMed ID: 29048965
[TBL] [Abstract][Full Text] [Related]
19. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer.
Czoski-Murray C; Karnon J; Jones R; Smith K; Kinghorn G
Health Technol Assess; 2010 Nov; 14(53):iii-iv, ix-x, 1-101. PubMed ID: 21083999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
